Witty remarks presage planetary alignment for GSK and India’s Biological E?
This article was originally published in Scrip
Executive Summary
It seems as though the planets may be aligning for a GlaxoSmithKline buy in India in the wake of speculation that the biologics division of the company have been eyeing up some part of the vaccines business of Biological E, one of India's first private sector biological products company.